APC Anti-Human CD44 Antibody[P2A1] (E-AB-F1038E) elabscience

$204.00
In stock
SKU
E-AB-F1038E
SizePrice (USD)
100Tests$204.00
20Tests$78.00
100Tests×2$312.00

Product Details

AbbreCD44
SynonymsMDU2MDU3MIC4, CD44, CD44 antigen, CDw44, Epican, LHR, PGP-1, PGP-I, Phagocytic glycoprotein 1, Phagocytic glycoprotein I
SwissprotP16070
ReactivityHuman
HostMouse
ClonalityMonoclonal
CloneP2A1
IsotypeMouse IgG2a, κ
Isotype ControlAPC Mouse IgG2a, κ Isotype Control[C1.18.4]
ApplicationsFCM
ConjugationAPC
Concentration5 μL/Test
BufferPhosphate buffered solution, pH 7.2, containing 0.09% stabilizer.
Research AreasCell Biology, Immunology
Cellular LocalizationMembrane

Product Description

Conjugation Information: APC is designed to be excited by the Red (627-640 nm) laser and detected using an optical filter centered near 660 nm (e.g., a 660/20 nm bandpass filter).

Background: CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from a low or mid level of intensity to high expression levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Storage and Shipping

StorageThis product can be stored at 2-8°C for 24 months. Please protected from prolonged exposure to light and do not freeze.
ShippingIce bag
  1. The simultaneous targeted Inhibition of ISG15 and HMGCR disrupts cancer stemness through metabolic collapse and induces synthetic lethality in pancreatic ductal adenocarcinoma
    Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | Year: 2025 | Impact Factor: 12.800
    DOI: 10.1186/s13046-025-03561-x | Reactivity: Human | Sample Type: BxPC3 cell,SW1990 cell
  2. HBx Drives Liver Cancer Stem Cell Generation Through Stimulating Glucose Metabolic Reprogramming
    Journal: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | Year: 2025 | Impact Factor: 4.200
    DOI: 10.1111/jcmm.70722 | Reactivity: Human | Sample Type: Huh7 cell,HepG2 cell,PLC/PRF/5 cell
  3. Non-glycanated 螖DCN isoform in muscle invasive bladder cancer mediates cancer stemness and gemcitabine resistance
    Journal: CELLULAR ONCOLOGY | Year: 2024 | Impact Factor: 4.900
    DOI: 10.1007/s13402-024-00998-8 | Reactivity: Human | Sample Type: bladder cancer stem cell (BCSCs)
  4. EMF treatment delays mesenchymal stem cells senescence during long-term in vitro expansion by modulating autophagy
    Journal: Frontiers in Cell and Developmental Biology | Year: 2024 | Impact Factor: 4.600
    DOI: 10.3389/fcell.2024.1489774 | Reactivity: Rat | Sample Type: bone marrow mesenchymal stem cell (BMSCs)
  5. Sodium Houttuyfonate Ameliorates DSS-induced Colitis Aggravated by Candida albicans through Dectin-1/NF-魏B/miR-32-5p/NFKBIZ Axis Based on Intestinal microRNA Profiling
    Journal: INFLAMMATION | Year: 2024 | Impact Factor: 4.500
    DOI: 10.1007/s10753-024-02091-6 | Reactivity: Human | Sample Type: Caco2 cell
  6. Plexin-B2 Mediates Orthodontic Tension-Induced Osteogenesis via the RhoA/F-Actin/YAP Pathway
    Journal: JOURNAL OF PERIODONTAL RESEARCH | Year: 2024 | Impact Factor: 3.400
    DOI: 10.1111/jre.13358 | Reactivity: Human | Sample Type: periodontal ligament stem cell (PDLSCs)

Reviews

Write Your Own Review
You're reviewing:APC Anti-Human CD44 Antibody[P2A1] (E-AB-F1038E) elabscience
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.